HCW Biologics Prices $1.6M Private Placement Of 618,682 Units At A Price Of $2.5849/Unit
HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to treat autoimmune diseases, cancer
HCW Biologics raised $1.6 million by selling shares to investors at $2.58 per share. When a company does this, it means they need money to keep working on their science—so watch if they're making progress on their treatments.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.